Back
SPAR Group, Inc. 10K Form
Sell
30
SGRP
SPAR Group, Inc.
Last Price:
$0.90
Seasonality Move:
4.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-15 | 10Q | SGRP/SPAR Group, Inc. Quarterly |
| 2023-11-14 | 10Q | SGRP/SPAR Group, Inc. Quarterly |
| 2023-08-14 | 10Q | SGRP/SPAR Group, Inc. Quarterly |
| 2023-05-22 | 10Q | SGRP/SPAR Group, Inc. Quarterly |
| 2022-11-14 | 10Q | SGRP/SPAR Group, Inc. Quarterly |
| 2022-08-15 | 10Q | SGRP/SPAR Group, Inc. Quarterly |
Receive SGRP News And Ratings
See the #1 stock for the next 7 days that we like better than SGRP
SGRP Financial Statistics
Sales & Book Value
| Annual Sales: | $163.6M |
|---|---|
| Cash Flow: | $-4.6M |
| Price / Cash Flow: | 8.5 |
| Annual Sales: | $0.70 |
| Price / Book: | 1.26 |
Profitability
| EPS (TTM): | -0.91650 |
|---|---|
| Net Income (TTM): | $-22M |
| Gross Margin: | $32M |
| Return on Equity: | -91.7% |
| Return on Assets: | -33.59% |
SPAR Group, Inc. Earnings Forecast
Key SPAR Group, Inc. Financial Ratios
-
The Gross Profit Margin over the past 30 years for SGRP is 19.58%.
-
The Selling, General & Administrative Expenses for SGRP have been equal to 20.71% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of SGRP is -1.10% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 13 years.
SPAR Group, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Media |
| Sector: | Communication Services |
| Current Symbol: | SGRP |
| CUSIP: | 784933 |
| Website: | sparinc.com |
Debt
| Debt-to-Equity Ratio: | 1.58 |
|---|---|
| Current Ratio: | 1.2 |
| Quick Ratio: | 1.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 7.25 |
|---|---|
| Forward P/E Ratio: | 0 |
SGRP Technical Analysis vs Fundamental Analysis
Sell
30
SPAR Group, Inc. (SGRP)
is a Sell
Is SPAR Group, Inc. a Buy or a Sell?
-
SPAR Group, Inc. stock is rated a SellThe current SPAR Group, Inc. [SGRP] share price is $0.88. The Score for SGRP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.